{"id":"W3005453403","doi":"10.1200/jco.2020.38.5_suppl.54","title":"Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); University Health Network; Windsor Regional Hospital; Juravinski Cancer Centre; McMaster University; Princess Margaret Cancer Centre; BC Cancer Agency; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Nivolumab; Pembrolizumab; Internal medicine; Lung cancer; Oncology; Immunotherapy; Clinical endpoint; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006912875,0.0004101784,0.0004640018,0.001181268,0.001858284,0.001140004,0.0009503936,0.0005803035,0.001436277],"category_scores_gemma":[0.002397072,0.0002774103,0.00071951,0.003944862,0.000633519,0.0003778542,0.0008283905,0.000618464,0.0002209817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04056244,"about_ca_system_score_gemma":0.03304766,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.983395,"about_ca_topic_score_gemma":0.9887835,"domain_scores_codex":[0.9988981,0.00007018574,0.0000994296,0.0001706429,0.0004045159,0.0003571172],"domain_scores_gemma":[0.9965889,0.0001130787,0.0009865044,0.00007077906,0.001515017,0.0007257217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001402748,0.00001970421,0.9958622,0.00005229489,0.00005875278,0.0001268683,0.0002020954,0.0001741364,0.00008308107,0.00005878988,0.001070262,0.002151532],"study_design_scores_gemma":[0.00002502959,0.00007337149,0.9968262,0.0000494954,0.00005817441,0.0002082612,0.0007522364,0.0004487569,0.00007340103,0.00003332373,0.001434541,0.00001735398],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980771,0.001453613,0.000109684,0.000661588,0.00001740012,0.0001193064,0.01435613,0.0000159071,0.00249534],"genre_scores_gemma":[0.9942399,0.0004307801,0.0001459067,0.0001903634,0.000009797159,0.00003253431,0.004538487,0.000003768549,0.0004084364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04056244,"threshold_uncertainty_score":0.2943025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06196130539225674,"score_gpt":0.3975799223295604,"score_spread":0.3356186169373037,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}